Alnylam Pharmaceuticals, Inc. (ALNY) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$313.12
Day's range
$323.68

Alnylam Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 05/15/2026 14.58 M $4.82 B   -8.32% 11.03%
CAPITAL WORLD INVESTORS 05/13/2026 10.80 M $3.57 B   -33.74% 8.17%
BLACKROCK, INC. 05/13/2026 10.44 M $3.46 B   0.42% 7.90%
CAPITAL RESEARCH GLOBAL INVESTORS 05/13/2026 9.47 M $3.13 B   39.70% 7.16%
05/08/2026 6.49 M $2.15 B   100.00% 4.91%
JPMORGAN CHASE & CO 05/13/2026 6.32 M $2.00 B   33.98% 4.78%
05/15/2026 5.95 M $1.97 B   100.00% 4.50%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 05/15/2026 5.19 M $1.72 B   196.15% 3.93%
STATE STREET CORP 05/15/2026 3.32 M $1.10 B   2.90% 2.51%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 2.66 M $884.57 M   0.36% 2.01%
BAILLIE GIFFORD & CO 05/08/2026 2.49 M $825.15 M   -4.12% 1.89%
TWO SIGMA INVESTMENTS, LP 05/15/2026 1.99 M $659.28 M   223.41% 1.51%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 1.94 M $640.54 M   18.85% 1.46%
DODGE & COX 05/14/2026 1.93 M $638.33 M   -1.79% 1.46%
AMERICAN CENTURY COMPANIES INC 05/15/2026 1.80 M $596.35 M   21.36% 1.36%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 1.43 M $474.06 M   -15.86% 1.08%
CLEARBRIDGE INVESTMENTS, LLC 05/13/2026 1.36 M $448.67 M   127.14% 1.03%
ORBIS ALLAN GRAY LTD 05/15/2026 1.33 M $441.65 M   -17.51% 1.01%
INVESCO LTD. 05/12/2026 1.29 M $427.39 M   -40.36% 0.98%
MARSHALL WACE, LLP 05/15/2026 1.10 M $363.73 M   99.90% 0.83%
D. E. SHAW & CO., INC. 05/15/2026 1.06 M $350.41 M   138.26% 0.80%
MORGAN STANLEY 05/15/2026 1.00 M $331.76 M   3.35% 0.76%
BANK OF AMERICA CORP /DE/ 05/18/2026 966.91 K $319.92 M   41.12% 0.73%
LEGAL & GENERAL GROUP PLC 05/08/2026 934.88 K $309.32 M   -2.77% 0.71%
AQR CAPITAL MANAGEMENT LLC 05/15/2026 913.10 K $297.87 M   -0.75% 0.69%
NORTHERN TRUST CORP 05/14/2026 858.12 K $283.93 M   0.04% 0.65%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 840.89 K $278.22 M   100.00% 0.64%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 838.19 K $277.33 M   8.20% 0.63%
ROYAL BANK OF CANADA 05/15/2026 791.52 K $261.89 M   33.82% 0.60%
DEUTSCHE BANK AG\ 05/06/2026 761.46 K $251.95 M   6.95% 0.58%
AMUNDI 05/18/2026 747.54 K $247.34 M   22.77% 0.57%
FEDERATED HERMES, INC. 05/11/2026 687.82 K $227.58 M   9.51% 0.52%
UBS ASSET MANAGEMENT AMERICAS INC 05/13/2026 677.52 K $224.17 M   3.86% 0.51%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 673.36 K $222.79 M   3.94% 0.51%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 05/15/2026 662.37 K $219.16 M   944.54% 0.50%
LOOMIS SAYLES & CO L P 05/14/2026 512.10 K $169.44 M   4.75% 0.39%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 05/14/2026 496.00 K $164.11 M   0.14% 0.38%
BANK OF NEW YORK MELLON CORP 05/05/2026 491.20 K $162.52 M   -2.57% 0.37%
FRANKLIN RESOURCES INC 05/13/2026 470.39 K $155.64 M   -40.28% 0.36%
GOLDMAN SACHS GROUP INC 05/15/2026 469.39 K $155.31 M   25.06% 0.36%
UBS GROUP AG 05/05/2026 458.87 K $151.83 M   -44.44% 0.35%
MILLENNIUM MANAGEMENT LLC 05/15/2026 447.89 K $148.19 M   493.78% 0.34%
SQUAREPOINT OPS LLC 05/15/2026 426.72 K $141.19 M   21.58% 0.32%
D. E. SHAW & CO., INC. 05/15/2026 408.80 K $135.26 M   2.92% 0.31%
RAYMOND JAMES FINANCIAL INC 05/14/2026 406.96 K $129.97 M   4.70% 0.31%
SWISS NATIONAL BANK 05/07/2026 387.72 K $128.28 M   7.94% 0.29%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 384.21 K $127.07 M   27.28% 0.29%
FIRST TRUST ADVISORS LP 05/13/2026 382.70 K $126.62 M   48.94% 0.29%
WELLS FARGO & COMPANY/MN 05/11/2026 370.00 K $122.42 M   0.00% 0.28%
WELLS FARGO & COMPANY/MN 05/11/2026 342.76 K $113.41 M   33.04% 0.26%

Alnylam Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 1112 institutional investors and hedge funds held shares of Alnylam Pharmaceuticals Inc. The most heavily invested institutionals were:

FMR LLC: 14.58 M

Capital World Investors: 10.8 M

BlackRock, Inc.: 10.44 M

Capital Research Global Investors: 9.47 M

JPMORGAN CHASE & CO: 6.32 M

T. Rowe Price Investment Management, Inc.: 5.19 M

97.23% of Alnylam Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 154.59 M shares in the last 24 months. This purchase volume represents approximately $50.02 B in transactions.